Autologous Cell Therapy Process in Lakhesys -
The Benchtop Cell Factory™

Improving
End-to-End Manu­facturing

through Miniaturization

astraveus-process-icon-1

Magnetic Enrichment

astraveus-process-icon-2

Microfluidic Enrichment

astraveus-process-icon-3

Activation

astraveus-process-icon-4

Transduction

astraveus-process-icon-5

Washing

astraveus-process-icon-6

Expansion

astraveus-process-icon-7

Formulation

astraveus-process-icon-8

Product output

Why Microfluidics?

Microfluidics for
best-in-class cell processing

1000x

Less microfluidic Routing Volume

Lakhesys™ technology minimizes “useless” reagent consumption to fill and prime non-processing space.

1000x

Stronger Cell-Reactant Contact

Maximizing speed and yield of all reaction steps compared to flasks or other settled culture conditions.

35x

More conditions

Optimization of multiple critical process parameters in a DoE setting

10⁶ to 10⁹

Bioprocessor Cell Capacity

Process can be linearly scaled down to proportionally reduce reactant consumption while maintaining process parameters.

astraveus-gas-transfer

Publications

A novel microfluidic cell factory to optimize and scale cgt manufacturing.

Have questions or ideas? Reach out to Astraveus to learn more about our groundbreaking work in biotechnology, or to explore partnership opportunities.

79, Avenue de Fontainebleau
94270 Le Kremlin-Bicêtre
France